{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:56:46Z","timestamp":1769194606627,"version":"3.49.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Serotonin syndrome (SS) is a serious toxicity that manifests with symptoms such as tremor, hyperthermia, agitation, and altered mental status that may lead to seizures, coma, or death. Selective serotonin reuptake inhibitors may precipitate SS, particularly in combination with other drugs that possess serotonergic activity. We present a case of SS in a 14-month-old after an ingestion of the selective serotonin reuptake inhibitor vilazodone.<\/jats:p>","DOI":"10.1097\/pec.0000000000001115","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T20:12:22Z","timestamp":1490731942000},"page":"e226-e228","source":"Crossref","is-referenced-by-count":4,"title":["Serotonin Syndrome in a Pediatric Patient After Vilazodone Ingestion"],"prefix":"10.1097","volume":"34","author":[{"given":"Benjamin","family":"Laliberte","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Massachusetts General Hospital, Boston, MA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omayma A.","family":"Kishk","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, University of Maryland Medical Center, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230930","first-page":"310","article-title":"Overview of serotonin syndrome","volume":"24","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"bib2-20230930","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"bib3-20230930","first-page":"33","article-title":"Serotonin syndrome: a concise review of a toxic state","volume":"97","year":"2014","journal-title":"R I Med J"},{"key":"bib4-20230930","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","year":"1991","journal-title":"Am J Psychiatry"},{"key":"bib5-20230930","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","year":"2003","journal-title":"QJM"},{"key":"bib8-20230930","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"bib9-20230930","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/15563650.2012.678497","article-title":"Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children","volume":"50","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"bib10-20230930","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/15563650701285289","article-title":"Selective serotonin reuptake inhibitor poisoning: an evidence-based consensus guideline for out-of-hospital management","volume":"45","year":"2007","journal-title":"Clin Toxicol (Phila)"},{"key":"bib11-20230930","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.annemergmed.2012.06.020","article-title":"Recurrent seizure activity in a child after acute vilazodone ingestion","volume":"60","year":"2012","journal-title":"Ann Emerg Med"},{"key":"bib12-20230930","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jemermed.2015.04.032","article-title":"Acute vilazodone toxicity in a pediatric patient","volume":"49","year":"2015","journal-title":"J Emerg Med"},{"key":"bib13-20230930","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults","volume":"3","year":"2011","journal-title":"Pharmaceutics"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006565-201812000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T08:16:44Z","timestamp":1696061804000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006565-201812000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000001115","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}